Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Mela Sciences’ MelaFind PMA amendment

You may also be interested in...



CMS Urged To Expand Eligible Settings For Sexually Transmitted Disease Screenings

To help ensure that Medicare beneficiaries receive appropriate access to screening tests for sexually transmitted infections, CMS should explicitly cover such tests even when they are ordered or performed outside the primary care setting, stakeholders say.

CMS Urged To Expand Eligible Settings For Sexually Transmitted Disease Screenings

To help ensure that Medicare beneficiaries receive appropriate access to screening tests for sexually transmitted infections, CMS should explicitly cover such tests even when they are ordered or performed outside the primary care setting, stakeholders say.

Groups Weigh In On Screening Frequency For Sexually Transmitted Infections

The American Society for Microbiology is urging CMS not to impose frequency limitations on screening for sexually transmitted infections, because risk factors “emerge or evolve over time.”

Related Content

Topics

UsernamePublicRestriction

Register

LL1134786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel